Memantine Hydrochloride 70771-1321-04
- Manufacturer
- Zydus Lifesciences Limited
- Dosage Form
- Capsule, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 8, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA203293
Need to source Memantine Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Memantine Hydrochloride | 7 mg/1 |
Drug Class
N-methyl-D-aspartate Receptor Antagonist [EPC]NMDA Receptor Antagonists [MoA]
Selected Package
70771-1321-04Selected10 BLISTER PACK in 1 CARTON (70771-1321-4) / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (70771-1321-2)
Other packages for this product(2)
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1321-3)
90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1321-9)